文献速递脑血管病神经重症与神经感染

组织型纤溶酶原激活剂的统治是否终结

The End of Tissue-Type Plasminogen Activator's Reign?
PubMed 文献 · Stroke · 2022-05-04

本文综述急性缺血性卒中大血管闭塞的再灌注治疗现状,讨论机械取栓前静脉溶栓的额外获益仍不明确,以及单次取栓完全再灌注应为首要血管造影目标;额外血管内尝试或局部溶栓药能否安全提高再灌注分级及公共卫生与成本影响尚未确定。

要点

  • 机械取栓对大血管闭塞性急性缺血性卒中高度有效,可显著提高功能独立恢复的可能性。
  • 静脉溶栓联合机械取栓的额外获益尚不明确。
  • 单次取栓实现完全再灌注应为首要血管造影目标。

核心结论

  • 静脉溶栓在前循环卒中中的一致治疗获益及辅助动脉内溶栓药(包括替代溶栓药)的潜在地位仍需探索。

研究设计与样本

  • 综述,概述当前知识状态与待探索的研究方向。

主要发现

  • 机械取栓是前循环大血管闭塞所致急性缺血性卒中的高效治疗,显著增加功能独立恢复的可能性。
  • 静脉溶栓联合机械取栓是否提供额外获益尚不明确。
  • 单次取栓实现完全再灌注应为首要血管造影目标。
  • 延长操作行额外血管内尝试或局部溶栓药给药能否安全提高再灌注分级尚不确定。
  • 额外尝试或局部溶栓药给药的公共卫生与成本影响尚不确定。

局限性

  • 静脉溶栓联合机械取栓的额外获益尚不明确。
  • 额外血管内尝试或局部溶栓药给药能否安全提高再灌注分级尚不确定。
  • 额外尝试或局部溶栓药给药的公共卫生与成本影响尚不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mechanical thrombectomy is a highly effective treatment for acute ischemic stroke caused by large-vessel occlusion in the anterior cerebral circulation, significantly increasing the likelihood of recovery to functional independence. Until recently, whether intravenous thrombolysis before mechanical thrombectomy provided additional benefits to patients with acute ischemic stroke-large-vessel occlusion remained unclear. Given that reperfusion is a key factor for clinical outcome in patients with acute ischemic stroke-large-vessel occlusion and the efficacy of both intravenous thrombolysis and mechanical thrombectomy is time-dependent, achieving complete reperfusion with a single pass should be the primary angiographic goal. However, it remains undetermined whether extending the procedure with additional endovascular attempts or local lytics administration safely leads to higher reperfusion grades and whether there are significant public health and cost implications. Here, we outline the current state of knowledge and research avenues that remain to be explored regarding the consistent therapeutic benefit of intravenous thrombolysis in anterior circulation strokes and the potential place of adjunctive intra-arterial lytics administration, including alternative thrombolytic agent place.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Derraz I. The End of Tissue-Type Plasminogen Activator's Reign? Stroke. 2022. PMID: 35506385. doi:10.1161/STROKEAHA.122.039287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。